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Introduction 1
Heat shock factor 1 (HSF1) is an evolutionarily conserved transcription factor that initiates the 2 cytoprotective heat shock response (HSR). Found throughout the eukaryotic kingdom, HSF1 3 allows for the cellular adaptation to proteotoxic stress 1 . Through an incompletely defined 4 mechanism, mammalian HSF1 monomers in cytosol are activated and form trimers, translocate 5 into the nucleus, and bind sequences of DNA known as heat shock elements (HSE), ideally 6 represented as nGAAnnTTCnnGAAn 2 3 . Throughout this process HSF1 is heavily post-7 translationally modified and interacts with numerous cellular components. The binding of HSF1 8 trimers to HSE induces the transcription of a specialized set of genes known as molecular 9 chaperones while also repressing the expression of other genes 4 5 , although the repressive effect 10 of HSF1 is controversial 6 . Once expressed, these molecular chaperones (or Heat Shock Proteins, 11
HSPs) act to stabilize the three-dimensional structure of numerous cellular proteins, thus helping 12 to maintain cellular proteostasis. HSP90 and HSP70 are ATP-dependent HSPs that interact with 13 a large sector of the eukaryotic proteome while also modulating HSF1 transcriptional activity 7 8 14 9 . The relationship between HSF1 and one or more components of the cellular proteostasis 15 network is thought to represent a primary axis in the control of the HSR 7 10 . 16
In cancer, HSF1 enables malignant cell growth and is overexpressed in a number of tumor types 17 associated with poor prognosis 11 12 13 . Although HSF1 does not initiate oncogenic 18 transformation, tumors become addicted to HSF1 activity as their microenvironments become 19 increasingly toxic and as they require higher levels of HSPs to maintain proteostasis 14 . 20 Moreover, many oncogenes that drive tumorigenesis are metastable and rely on HSPs to sustain 21 their activity. This is particularly true for mutated or overexpressed kinases and transcription 22 factors that interact with HSP90 15 . HSF1 also promotes a cancer-specific transcriptional 23 program that supports malignancy through the expression of genes for proliferation, anabolic 24 7 with plasmids encoding FLAG-tagged wild type or conformationally restricted HSP90 proteins 1 together with wild type HA-HSF1, harvested the cells the following day, and observed the 2 protein-protein interactions by anti-FLAG immunoprecipitation-western blot (IP-WB) analysis 3 ( Figure 1B, C) . The relative expression of HSF1 in transfected and untransfected cells is shown 4 in Supplemental Figure 1A . We found that wild type HSF1 strongly interacts, without the need 5 for crosslinking, with both "closed" HSP90 mutants but not with the pair of "open" HSP90 6 mutants. Importantly, the results with transfected HSF1 were confirmed by co-7 immunoprecipitation of "closed" HSP90 with endogenous HSF1 in HEK293 cells (Supplemental 8 Figure 1B ). As previously reported 7 , interaction of wild type HSP90, which samples all 9 available conformational states, with full-length HSF1 is not detectable in the absence of protein 10 crosslinking. This result is consistent with the observation that human HSP90, in contrast to the 11 yeast chaperone, is most likely to be found in the "open" conformation, even when ATP is bound 12 37 . Moreover, we observed that HSP90α E47A bound more avidly to HSF1 than did HSP90β 13 E42A, suggesting that the stress-inducible HSP90α isoform may be a stronger negative regulator 14 of HSF1 activity compared to the constitutively expressed HSP90β isoform, as previously 15 proposed 36 . 16
To further assess the interaction between wild type HSF1 and the "closed" HSP90 mutants, we 17 repeated the reciprocal experiment in the absence or presence of the anion molybdate (MoO 4 ) 18
Molybdate has been reported to stabilize a high affinity client binding state of HSP90 38 . Target 19 proteins were pulled down via either FLAG-HSP90 or FLAG-HSF1 ( Figure 1C ). Although, the 20 HSF1/ "closed" HSP90 interaction was confirmed, molybdate only moderately increased the 21 interaction of the "closed" HSP90 mutants with no discernable effect on interaction of wild type 22 HSP90 with HSF1, indicating that HSP90 interacts with HSF1 in a manner that is likely unique 23 when compared to other clients such as protein kinases 38 39 . 24 8 Administration of HSP90 inhibitors often results in apparent induction or augmentation of the 1 HSR. Currently, there are two general classes of inhibitors. The more clinically advanced N-2 terminal inhibitors competitively bind to the ATP pocket and prevent or disrupt nucleotide-3 dependent N-domain dimerization 40 . These inhibitors include 17AAG (tanespimycin), STA9090 4 (ganetespib) and SNX2112, among others 30 . A second class of inhibitors, based on the antibiotic 5 novobiocin, binds a putative nucleotide-binding domain in the C-terminal portion of HSP90 6 (adjacent to the C-terminal dimerization domain) and inhibits the chaperone in a distinct manner 7 41 . The synthetic novobiocin derivative KU32 is representative of this class of inhibitors 42 . To 8 explore how N-and C-terminal inhibitors might affect HSF1/HSP90 interaction, we co-9 transfected HEK293 cells with wild type HA-HSF1 and FLAG-HSP90α E47A, briefly treated 10 cells with inhibitors the following day, harvested and analyzed protein-protein interactions by IP-11 WB ( Figure 1D , Supplemental Figure 1C ). Each of the three N-terminal inhibitors disrupted the 12 interaction between HSF1 and HSP90α E47A, consistent with their disruption of N-domain 13 dimerization. In contrast, KU32 did not disrupt the interaction between HSF1 and "closed" 14 HSP90, indicating that this is a unique property of ATP-competitive, N-terminal HSP90 15 inhibitors. 16
Mapping of HSP90 and HSP70 interactions across HSF1 17
To investigate the interactions of HSP90 and HSP70 with HSF1 in the absence of a crosslinking 18 agent, we constructed and transiently expressed in HEK293 cells a series of HSF1 truncation and 19 internal deletion mutants, and we analyzed them for chaperone interaction by IP-WB ( Figure 2A  20 and B). Of note, N195, an N-terminal truncation mutant lacking the DBD and most of the HR-21 A/B domain, expressed very poorly (see blot in Figure 2B ) and data obtained using this mutant 22 should be considered in this context. These HSF1 constructs were used to initially query the 23 interaction of HSP90 and HSP70 across the TAD, HR-C, RD, HR-A/B and DBD domains of 24 HSF1 (Supplemental Figure 2A, B) . 25 9 Based on these preliminary data obtained with the closed HSP90 mutants, a subpanel of HSF1 1 truncation and deletion mutants were selected to assess association of HSP90α E47A. 2 Pulldowns were repeated in triplicate, resulting blots were subjected to densitometry to generate 3 mean values +/-standard deviations and p values to assess significance (compared to association 4 of HSP90α E47A with full length HSF1) were obtained. These data are shown in Figure 2 , 5 panels C and D. Analysis of HSF1 C-terminal truncations revealed a distinct interaction motif for 6 "closed" HSP90 E47A ( Figure 2C ). The "closed" mutant bound most intensely to HSF1 7 proteins containing the HR-A/B domain and a portion of the heat-sensing RD, but lacking the 8 HR-C and TAD. The clear difference in HSP90 interaction between the C442 and C383 HSF1 9 truncation mutants suggests that presence of the HSF1 HR-C + TAD domain inhibits HSP90 10 interaction. Although HSP90 E47A bound weakly to more extensive C-terminal truncations, 11 binding was not significantly different from wild type HSF1. The dual importance of both the 12 HR-A/B and RD domains for HSP90 binding is supported by the observation that neither the 13 isolated HR-A/B domain (N120-C205, Figure 2D and Supplemental Figure 2B ) nor the isolated 14 RD domain (N262-C383, Supplemental Figure 2B ) display binding to HSP90. 15 Importantly, deletion of the HR-C domain dramatically improves the binding of both "closed" 16 and endogenous HSP90, suggesting that HR-C intermolecular binding to HR-A/B (characteristic 17 of inactive HSF1 monomers) interferes with HSP90 binding and providing further evidence that 18 is inconsistent with a role for HSP90 in sequestering monomeric HSF1. Finally, the HSF1 HR-19 A/B internal deletion construct DEL142-169, where amino acids 142-169 were removed, bound 20 "closed" HSP90 while the HR-A/B internal deletion construct DEL183-214 did not ( Figure 2D  21 and Supplemental Figure 2D ), suggesting that the C-terminal half of the HR-A/B is necessary for 22 HSP90 binding. 23
While the binding pattern of endogenous HSP90 generally mirrors that of "closed" HSP90 24 (although, in contrast to "closed" HSP90, detectable binding of endogenous HSP90 requires 25 10 deletion of the HR-C domain, see Supplemental Figure 2A , B), endogenous HSP90 also uniquely 1 binds the HSF1 constructs N195 and N262 but not the equivalent HSF1 mutants lacking the HR-2 C and TAD domains (N195-C383 or N262-C383, see Supplemental Figure 2B ). These findings 3 are consistent with the interaction of endogenous HSP90 (primarily existing in an N-domain 4 undimerized conformation) with the HR-C domain, as recently reported by Mayer and 5 colleagues for HSP90β. Importantly, these authors demonstrated that HSP90 binding to the 6 HSF1 HR-C domain promotes its temperature-sensitive dissociation from HR-A/B, thus 7 facilitating HSF1 trimerization 25 . Like our data, these findings are also not consistent with a role 8 for HSP90 in suppressing HSF1 trimerization. 9
In contrast to the binding profile of HSP90, endogenous HSP70 interacts robustly with full-10 length HSF1 as well as with most of the C-terminal truncation and deletion mutants 11 (Supplemental Figure 2A and B), with the exception of those mutants containing increasingly 12 truncated RD. Endogenous HSP70 also bound poorly to N120-C205 (isolated HR-A/B domain) 13 despite ample expression of this HSF1 protein fragment. Taken together, these data identify the 14 RD as being sufficient for HSP70 binding in unstressed cells, although HSP70 binding to other 15 domains of HSF1 has also been reported 26 27 . 16
To further compare the role of the HR-A/B domain in HSF1 trimerization and in HSP90 17 interaction, we made a set of alanine scanning mutants (145A 4 , 151A 5 , 161A 5 ) between amino 18 acids142-169 (see Methods) and compared them in the experiments below with the internal 19 deletion constructs DEL142-169 and DEL183-214. Using IP-WB analysis of co-transfected WT 20 HA-HSF1 and mutant FLAG-HSF1, we observed that the HR-A/B domain alanine mutants did 21 not disrupt HSF1 intermolecular interaction, in distinct contrast to the HR-A/B deletion mutants 22 DEL142-169 and DEL182-214 (Supplemental Figure 2C ). In contrast, these alanine mutants 23 bound "closed" HSP90α E47A to a greater extent compared to WT HSF1 (but similarly to 24 DEL142-169 (Supplemental Figure 2D and Figure 2D ). These data are consistent with the 25 hypothesis that the HR-A/B region contributing to HSF1 trimerization is distinct from the HR-1 A/B region that is required for HSP90 binding. Further, our findings emphasize that the presence 2 or absence of HSP90 binding has no impact on HSF1 trimerization (see Figure 3B , D and 3 Supplemental Figure 5 ). Finally, the enhanced HSP90 binding of the HSF1 truncation and 4 deletion mutants shown in Figure 2C , D does not involve possible heterotrimerization of the 5 transfected HSF1 constructs with endogenous HSF1, as similar results are obtained when the 6 HSF1 truncation mutants are transfected into HEK293 cells stably knocked down for 7 endogenous HSF1 (Supplemental Figure 2E ). 8
The TAD and DBD are essential for HSF1 transcriptional activity while the HR-A/B 9 domain is required for dominant negative activity of truncated HSF1 10
To further explore potential relationships between the ability of HSF1 to (1) form intermolecular 11 trimers, (2) activate transcription, and (3) interact with HSP90, we examined the impact of HSF1 12 N/C-truncations and internal deletions on hsp70 promoter-reporter activity as a readout of the 13 HSR, and we complemented these observations with IP-WB analysis of HSF1 trimerization and 14 HSF1-HSP90 interaction. Overexpression of WT HSF1 increased hsp70-reporter activity in 15 response to heat shock by nearly 2-fold above a pcDNA control. Brief pretreatment of cells with 16 17AAG prior to heat shock increased hsp70-reporter activity in pcDNA control by 3.5-fold 17 compared to heat shock alone, and a similar fold increase in reporter activity was observed upon 18 17AAG exposure prior to heat shock in cells transfected with WT HSF1 ( Figure 3A ). For 19 reference, reporter activity in response to 17AAG alone, compared to heat shock and heat shock 20 + 17AAG is shown in Supplemental Figure 3A . Both heat-induced and 17AAG + heat-induced 21 hsp70-reporter activity were progressively impacted by increasing truncation of the TAD (C-22 terminal deletion constructs C509, C477 and C442), consistent with the importance of this 23 domain in modulating HSF1 activation 43 . Complete removal of TAD, HR-C and RD domains 24 (constructs C383 through C205) fully repressed hsp70-reporter activity even with 17AAG 25 pretreatment, suggesting that the presence of the HR-A/B domain of these mutants is essential 1 for dominant-negative activity, as a consequence of disrupting endogenous HSF1 trimers. Indeed, 2 truncation through the C-terminal portion of the HR-A/B domain (C182) restored hsp70-reporter 3 response to that seen after treating pcDNA control cells with heat and heat + 17AAG. Consistent 4 with this result, HSF1 C182 is unable to form an intermolecular interaction with wild type HSF1, 5 as are additional HR-A/B truncations ( Figure 3D ). Unexpectedly, further truncation (C167, C146 6 and C129) through the HR-A/B, increased hsp70-reporter activity above that of the pcDNA 7 control, suggesting the presence of a repressing motif located between amino acids 167 and 182 8 of HSF1 ( Figure 3A ). 9
Our previous observation of HSP90 binding to a series of RD-containing C-terminal truncation 10 mutants (C383, C339, C311, Figure 2C ) suggested that HSP90 binding might be involved in 11 repressing HSF1-driven hsp70-reporter activity. To address this possibility, we used IP-WB to 12 investigate the effect of 17AAG on the interaction of HSP90α E47A with these HSF1 RD 13 truncation mutants since these mutants repressed hsp70-reporter activity even in the presence of 14 17AAG ( Figure 3A) . Consistent with the data in Figure 2C , we observed increased binding of 15 HSP90α E47A to the RD truncation mutants C383, C339 and C311 when compared to wild type 16 HSF1. However, upon addition of 17AAG, HSF1-HSP90α E47A interaction was fully disrupted 17 ( Figure 3B ), while hsp70-reporter activity remained repressed ( Figure 3A ). These data indicate 18 that robust HSP90 interaction with HSF1 is not responsible for the dominant negative activity of 19 these mutants. Consistent with this hypothesis, the RD truncation mutant C287 bound poorly to 20 HSP90α E47A, yet displayed dominant negative activity (see Figures 3A and B ). Taken together, 21 our findings support the hypothesis that the dominant negative activity of HSF1 C-terminal 22 truncations retaining an intact HR-A/B domain is due to disruption of endogenous full length 23 HSF1 trimers necessary for transcriptional activity. 24 13 Next, we assessed the effects of another set of HSF1 N/C-terminal deletion constructs on hsp70-1 reporter activity ( Figure 3C ). Here we observed that the deletion constructs N120, N120-C383, 2 N120-C325 and N120-C287, all lacking the DBD but including an intact HR-A/B domain, 3 repressed hsp70-reporter activity below the level seen with empty plasmid, consistent with 4 dominant negative inhibition of endogenous HSF1. Removal of the HR-A/B domain (N195, 5 N262) relieved this repression to some extent, even when the TAD and RD were removed 6 (N195-C383, N195-C325, N262-C383, N262-C325). Finally, the internal HR-A/B deletion 7 mutants DEL142-169 and DEL182-214 supported hsp70-reporter activity at a level similar to 8 that of empty plasmid, confirming that an intact HR-A/B domain is required for dominant 9 negative activity. The statistical significance of the changes in reporter activity can be found in 10
Supplemental Figure 3B . Of note, these data are in contrast to the impact of these two HR-A/B 11 internal deletions on HSP90 binding ( Figure 2D , right two lanes). 12
To profile the ability of these deletion constructs to affect HSF1 intermolecular interaction 13 (indicative of trimerization capability), we analyzed by IP-WB the interaction of co-transfected 14 wild type HA-HSF1 with various FLAG-HSF1 deletion mutants. We found that FLAG-tagged 15 deletion mutants (C383, C287, C233, C205 and N120) that dominant negatively repressed 16 hsp70-reporter activity interacted efficiently (equivalent or enhanced interaction compared to 17 FLAG-tagged wild type HSF1) with wild type HA-HSF1. In contrast, deletion mutants (C182, 18 C167, C146, C129, DEL142-169, DEL183-214) that did not strongly repress hsp70-reporter 19 activity did not interact with WT HA-HSF1 ( Figure 3D ). We excluded N195 from this analysis 20 due to its poor expression as shown in Figures 2B and 3D . Likewise, the dominant negative 21 HSF1 mutants N120, N120-C383, N120-C325 and N120-C287 strongly interacted with full 22 length HSF1, while N195-C383 (which showed no dominant negative activity) did not 23 (Supplemental Figure 3C and D). Combined with our previous observations, these data further 24 confirm that HSF1 mutant-mediated dominant negative repression of endogenous HSF1-driven 25 14 transcription depends on the ability to form an intermolecular interaction with wild type HSF1. 1 A cartoon summarizing these data is provided in Figure 3E . 2 Impact of RD phosphorylation state on HSP90 inhibitor effect on HSF1 activity and 3 mobility shift in SDS-PAGE, and on HSF1 interaction with HSP90 4
Stress-inducible phosphorylation of the HSF1 RD coincides with acquisition of transactivation 5 capacity, although a functional requirement of RD phosphorylation for HSF1 activation has not 6 been demonstrated. Indeed, a recent report dissociates RD phosphorylation from HSF1 activation 7 and suggests that RD phosphorylation may serve as a rheostat to modulate the degree of 8 activation 23 . Since N-terminally targeted HSP90 inhibitors also cause a distinct, 9 phosphorylation-dependent mobility shift of HSF1 coincident with disrupting its association with 10 conformationally restricted HSP90 proteins (see Figure 1D , Supplemental Figure 1C and 11 Supplemental Figure 4) , we wished to determine whether these drugs promoted phosphorylation 12 of sites only within the RD and whether RD phosphorylation was a prerequisite for HSP90 13 inhibitor-enhanced HSF1 activity. For this purpose, we used the delta PRD (dPRD) HSF1 14 construct previously described, in which all phosphorylation sites within the RD have been 15 mutated to alanine (see Figure 4A ) 23 . Using the hsp70-reporter assay, we confirmed that dPRD 16 HSF1 was more sensitive to heat shock, and to the combination of heat shock and 17AAG, 17 compared to wild type HSF1 ( Figure 4B ). Unexpectedly, the mobility of HSF1 dPRD was also 18 shifted when challenged with three N-domain HSP90 inhibitors ( Figure 4C) , strongly suggesting 19 that HSP90 inhibitor-induced HSF1 phosphorylation is not restricted to site(s) within the RD 20 (Supplemental Figure 4) . Importantly, lack of phosphorylation within the RD domain does not 21 affect trimerization of either full length HSF1 or the various HSF1 deletion mutants discussed 22 above (Supplemental Figure 3E) . 23
HSP90 inhibition increases duration of HSF1 binding to hsp70 promoter and prolongs 24
duration of HSF1 transcriptional activity in response to heat shock 25 15 To assess the outcome of combining HSP90 inhibition with heat shock compared to either 1 inhibitor or heat shock alone, we monitored the extent and duration of HSF1 occupancy of the 2 hsp70 promoter by chromatin immunoprecipitation (ChIP) with antibody to HSF1. HEK293 cells 3 were pretreated for 1 hour at 37 o C with 10 μM 17AAG or left untreated, and then exposed to 4 heat shock (42 o C for 30 minutes). After recovery for varying times at 37 o C (no recovery, 2 hours, 5 4 hours, 6 hours), HSF1 ChIP was performed and pulldown of associated hsp70 promoter 6 sequences was assessed by PCR. An additional group exposed to 17AAG but in the absence of 7 heat shock was also subjected to ChIP analysis at the indicated times (based on recovery time 8 after heat shock). The top panel in Figure 5A shows a representative experiment in which the 9 expected PCR fragments were run on an agarose gel. In the bottom panel, PCR data reflecting 10 the extent and duration of HSF1 occupancy of the hsp70 promoter were quantified by 11 densitometry (3 independent experiments +/-standard deviation), normalized to input and 12 graphed as shown ( Figure 5A , values obtained in the absence of both heat shock and 17AAG 13 pretreatment were arbitrarily set to 1). In the absence of 17AAG, HSF1 binding to the hsp70 14 promoter was highest immediately after heat shock (no recovery). Promoter occupancy declined 15 below baseline by 2 hours and remained below baseline for the duration of the experiment. In 16 contrast, 1-hour pre-exposure of cells to 17AAG prior to heat shock resulted in an increased 17 duration of HSF1 binding to the hsp70 promoter (significantly above baseline at 2 hours of 18 recovery and significantly above the heat shock only value at later time points). Importantly, the 19 17AAG alone samples displayed the same maximal level of HSF1 binding to hsp70 promoter as 20 did both the heat shock alone samples and the heat shock + 17AAG samples. However, in 21 contrast to cells treated with heat shock alone, HSF1 promoter occupancy did not decline as 22 rapidly in cells treated with 17AAG alone or in combination with heat shock. Thus, the level of 23 HSF1 binding to DNA in these groups remained significantly above heat shock only values for 24 the full 6-hour recovery period (at least 4 hours longer than after exposure to heat shock alone). 25 16 Additionally, we assessed HSF1 transcriptional activity in HEK293 cells after heat shock alone, 1 17AAG alone, or after pre-exposure to 17AAG followed by heat shock, using the same 2 experimental conditions as for the ChIP analysis above ( Figure 5B ). For this purpose, we 3 examined endogenous HSP70 gene expression by RT-qPCR. Similar to the impact of heat shock 4 on HSF1 promoter occupancy, relative HSP70 mRNA expression peaked after 2 hours of 5 recovery from heat shock and declined thereafter to below baseline by 6 hours. In contrast, 6 17AAG alone promoted a modest increase in HSP70 mRNA (although below the peak seen after 7 heat shock) that remained elevated at 2 and 6 hours. After combined 17AAG treatment and heat 8 shock, HSP70 mRNA level increased on par with exposure to heat shock alone (similar values at 9 2 hours), but continued to increase to a peak value at 4 hours (25 % higher than the heat shock 10 alone peak value) that was maintained at 6 hours. Importantly, the 4-and 6-hour increase in 11 HSP70 mRNA after combination treatment was significantly higher (2 -2.5-fold) compared to 12 HSP90 inhibitor alone. 13
Discussion 14
In this study, we assessed the importance of HSP90 conformation for binding to HSF1 and we 15 found that only the ATP-dependent "closed" (e.g., N-domain dimerized) conformational mutants 16 E47A (HSP90α) and E42A (HSP90β) readily co-precipitate full-length HSF1, with HSP90α 17 displaying the stronger interaction. As HSP90α is stress-inducible and transcriptionally regulated 18 by HSF1, this provides an appealing feedback control mechanism to attenuate the HSR, 19 consistent with a model first proposed nearly twenty years ago 8 44 . Indeed, our previous finding 20 that transient over-expression of HSP90α reduced HSF1 transcriptional activity supports this 21 possibility 36 . In the absence of these conformationally restrictive mutations, mammalian HSP90 22 only rarely and transiently occupies the "closed" conformation, even in the presence of ATP, 23 with the bulk of the protein at steady-state occupying an N-domain undimerized conformation 37 . 24 This is inconsistent with a role for HSP90 in binding to and sequestering HSF1 monomers to 1 prevent trimerization, as has also been proposed 7 . 2
To identify chaperone binding sites in HSF1, we used a series of Flag-tagged HSF1 truncation 3 and internal deletion mutants to interrogate binding of HSP90 and HSP70, including the binding 4 of transiently expressed HSP90αΕ47Α or HSP90β Ε42Α. Using this approach, we identified a 5 region in HSF1 that associates most strongly with "closed" HSP90 (Supplemental Figure 5 ). This 6 motif is comprised of the HR-A/B trimerization domain in the context of a portion of the RD. 7
Binding of "closed" HSP90 to this motif is dramatically enhanced upon deletion of the HSF1 8
HR-C and TAD domains. Since the HR-C domain interacts with the HR-A/B domain to retard 9
HSF1 trimerization under basal conditions, these data are consistent with the preferential binding activity as a consequence of HSP70 binding to the TAD 26,27 . Our observation that HSP70 also 21 binds to the stress sensing RD may be relevant to the recent proposal that HSP70 provides an 22 on/off switch for dynamic regulation of stress-induced HSF1 activation in yeast 28 . Whether 23 HSP70 plays a similar role in regulating HSF1 activation in mammalian cells remains to be 24 explored. 25 18 We used these HSF1 truncation and deletion mutants to identify the HR-A/B domain as 1 necessary for dominant negative activity of HSF1 mutants lacking the TAD or the DBD. 2 Importantly, and consistent with our model, we found that HSP90 binding to the HR-A/B is not 3 required for dominant-negative activity as it is not reversed by 17AAG. Instead, dominant-4 negative activity depends on the ability to form an intermolecular interaction with other HSF1 5 monomers, suggesting that each monomer of an HSF1 trimer must be intact in order to attain 6 optimal HSF1 transcriptional activity. 7 A panel of clinically evaluated N-terminal HSP90 inhibitors uniformly enhance HSF1 8 phosphorylation coincident with dissociation of HSF1 from HSP90. One or more drug-sensitive 9 phosphorylation sites must lie outside of the RD, as an HSF1 protein with all putative RD 10 phosphorylation sites mutated to alanine (dPRD HSF1) still underwent a phosphorylation-11 dependent mobility shift upon HSP90 inhibitor treatment. We are currently exploring the 12 relevance of this observation to the activity of both wild type and dPRD HSF1, as well as the 13 mechanistic impact of HSP90 inhibitor-mediated HSF1 phosphorylation on its transcriptional 14 activity. 15 HSP90 ATP-competitive N-terminal inhibitors efficiently dissociate HSF1 from HSP90 "closed" 16 mutants, likely as a consequence of ATP displacement and subsequent disruption of N-domain 17 dimerization 40 . If ATP-bound, transiently N-domain dimerized HSP90 (including stress-18
inducible HSP90α) provides feedback control of the HSR by removing HSF1 trimers bound to 19 heat shock promoter elements, HSP90 inhibition and subsequent dissociation from HSF1 would 20 interfere with this process and would be predicted to prolong and/or intensify the HSR. 21
Consistent with this model, HSF1-CHiP data show that HSP90 inhibition alone and in 22
combination with a brief heat shock significantly enhanced the duration of HSF1 binding to 23 HSP70 promoter, compared to heat shock alone. When we assessed HSF1 transcriptional activity 24 after these treatments (monitoring endogenous HSP70 mRNA levels by RT-qPCR), we found 25 that pre-exposure to HSP90 inhibitor markedly enhanced the degree and significantly extended 1 the duration of HSP70 mRNA increase during recovery from a brief heat shock. HSP90 2 inhibition alone caused a moderate increase in HSP70 transcription, likely due to disruption of 3 the dynamic regulation of constitutive HSF1 activity in transformed cells, a phenomenon 4 recently described by Lindquist and colleagues 11 12 . 5
In summary, this report increases our understanding of the molecular mechanisms that regulate 6 HSF1 and the unique contribution of molecular chaperones, including HSP90 and HSP70, to this 7 process. While not precluding other possibilities, our findings are consistent with a role for 8 HSP90 in attenuating the HSR in an ATP-dependent and conformation-specific manner, a 9 process that is antagonized by ATP-competitive HSP90 inhibitors. A role for HSP90 in 10 disassembling transcriptional regulatory complexes has been described previously 45 . Our data 11 further suggest that, in contrast to HSP90, the readily observable interaction of endogenous 12 HSP70 with HSF1, and our observation that the RD represents a major interaction motif for this 13 chaperone, support the possibility that HSP70 may provide constitutive, stress-sensitive 14 repression of the HSR in mammalian cells. 15 16
Materials and Methods 1
Cell culture: HEK293 cells (American Type Culture Collection) were maintained in DMEM 2 supplemented with 10% FBS. Cells were grown in 6-well or 96-well plates to 50% confluency 3 and then transfected for 16-24 hours with X-tremeGENE 9 transfection reagent (Roche) 4 according to the provided protocol. HEK293 cells stably expressing an shRNA targeting HSF1 5 was obtained from Dr. Chengkai Dai (Center for Cancer Research, NCI) and has been described 6 previously 46 . 7
Reagents: 17AAG was obtained from the Developmental Therapeutics Program, NCI. STA9090 8 (ganetespib) and SNX2112 were obtained from Synta Pharmaceuticals and Esanex, respectively. 9
The C-terminal inhibitor KU32 was kindly provided by Dr. Brian Blagg (The University of 10 Kansas, Lawrence, KS). MG132 and molybdate were purchased from Sigma-Aldrich. All drugs 11 were used at 10 μ M for IP-WB or hsp70-reporter assays. HCl pH7.5, 5% Glycerol, 100 mM NaCl, 2 mM EDTA, 0.5% Triton X-100] containing protease 20 inhibitor cocktail and phosphatase inhibitor cocktail (Roche). Lysates were centrifuged at 21 maximum speed for 15 minutes at 4°C. Supernatants were subjected to BCA protein assay for 22 normalization, and then 40 μ g of protein were used as input lysate to confirm protein expression. 23
From remaining lysates, 700 μ g of protein were subjected to immunoprecipitation by addition of 24 21 40 μ l of Anti-FLAG M2 affinity beads (Sigma-Aldrich, A2220) or HA affinity beads (clone HA-1 7, Sigma-Aldrich, A2095) followed by incubation with rotation for 2 hours at 4°C. After 2 centrifugation, beads were washed 4 times with TGNET buffer. The proteins were then eluted 3 with 30 μ l of 2X SDS sample buffer by boiling at 95°C for 5 minutes. Subsequently, samples 4 were subjected to SDS-PAGE followed by western blotting. The following antibodies were used 5 for western blot: HSF1 (Santa Cruz, sc-13516), HSP90 (Enzo Life Science, ADI-SPA-835), 6 HSP70 (Enzo Life Sciences, ADI-SPA-810), HA (Rockland, 600-401-384), and FLAG (Sigma-7 Aldrich, A8592). 8
Additional Methods may be found in Supplemental Information. Materials and data generated in 9 this study are available upon request. 10 1 This study was supported by funds from the Intramural Research Program, National Cancer 2 Institute, Center for Cancer Research (L.N.). T.K was supported by a JSPS Research Fellowship 3 for Japanese Biomedical and Behavioral Researchers at NIH. We dedicate this paper to the 4 memory of Dr. Susan Lindquist, a friend and a pioneer in the study of molecular chaperones. 5
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